What Diseases can be Treated with TPS?

TPS in Research for Use in Other Neurodegenerative Diseases

Transcranial Pulse Stimulation (TPS) is originally a method for the treatment of Alzheimer’s disease in the early and middle stages of the disease, which is performed with the shockwave system NEUROLITH, which is approved for the treatment of the central nervous system in Alzheimer’s dementia. The effectiveness of the treatment has now been proven by numerous studies and scientific investigations (see: Transcranial Pulse Stimulation – Study Overview ).

Due to the function and active principles of the low-energy shock waves of TPS, research and science have already looked at other indications. In addition to Alzheimer’s dementia, whose treatment now also includes severe Alzheimer’s stages, these include almost all other forms of dementia, Parkinson’s disease, post-stroke conditions and in the psychiatric field Depression, attention deficit hyperactivity disorder (ADHD), Autism and Long-Covid disorders with neurological manifestations (Neuro-Covid).

All these indications are the subject of intensive and expansive clinical research in international studies and the scientific findings are supported by a large number of case studies and case reports from daily practice. Treatment with TPS shows highly encouraging results in all these neurodegenerative and neurophysiological diseases with increasingly valid data.

Transcranial Pulse Stimulation (TPS): Intensive research continues

Transcranial Pulse Stimulation (TPS) has proven to be a promising method for the treatment of various neurological and neurodegenerative diseases. TPS is currently being further researched in numerous international studies, observational studies, multicenter studies and placebo-controlled studies.

The progress made with TPS clearly shows that an exciting new chapter is opening up in medicine: Researchers and scientists are confident that this non-invasive brain stimulation method has the potential to make a significant contribution to the future of treating neurodegenerative and neurophysiological diseases. As research continues and new insights are gained, TPS offers an encouraging prospect for patients and medical professionals hoping for innovative ways to manage these complex conditions.